{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:08:46Z","timestamp":1768320526225,"version":"3.49.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Infections represent a significant source of morbidity and mortality after kidney transplantation in children. We review recent advances in epidemiology, assessment, prevention and treatment for several different infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Infections, such as bacterial urinary tract infection or opportunistic viral infection remain common, may be increasing and represent a large proportion of hospitalization. Extended antiviral agent use reduces the incidence of cytomegalovirus disease but its efficacy to reduce Epstein\u2013Barr virus disease remains controversial. Human herpesvirus-6 and hepatitis E virus represent new infections to keep in mind. Ureteral stenting increases the rate of early UTI. Several new vaccines are now available, but rates of complete vaccination pretransplant are low.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Infections remain a critical posttransplant issue associated with significant medical burdens. Emerging data on associated risk factors, assessment of and treatment for infections provide clinicians with new knowledge.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000728","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T19:24:47Z","timestamp":1545161087000},"page":"226-231","source":"Crossref","is-referenced-by-count":10,"title":["Renal transplantation and predisposition to opportunistic infections"],"prefix":"10.1097","volume":"31","author":[{"given":"Raja","family":"Dandamudi","sequence":"first","affiliation":[{"name":"Division of Pediatric Nephrology, Hypertension and Pheresis, Washington University School of Medicine and St Louis Children's Hospital, St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, University of Washington and Seattle Children's Hospital, Seattle, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas R.","family":"Dharnidharka","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Hypertension and Pheresis, Washington University School of Medicine and St Louis Children's Hospital, St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","article-title":"Infectious disease risks in pediatric renal transplantation","author":"Scaggs Huang","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"R2-20230918","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/snep.2001.24947","article-title":"Management of pediatric postrenal transplantation infections","volume":"21","author":"Dharnidharka","year":"2001","journal-title":"Semin Nephrol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00467-017-3737-x","article-title":"Infection-related hospitalizations after kidney transplantation in children: incidence, risk factors, and cost","volume":"32","author":"Hogan","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00467-015-3209-0","article-title":"Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age","volume":"31","author":"Lofaro","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/ajt.14169","article-title":"Relationship among viremia\/viral infection, alloimmunity, and nutritional parameters in the first year after pediatric kidney transplantation","volume":"17","author":"Ettenger","year":"2017","journal-title":"Am J Transplant"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-6143.2004.00350.x","article-title":"Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS","volume":"4","author":"Dharnidharka","year":"2004","journal-title":"Am J Transplant"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1600-6143.2006.01675.x","article-title":"Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report","volume":"7","author":"Puliyanda","year":"2007","journal-title":"Am J Transplant"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/petr.12625","article-title":"Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients","volume":"20","author":"Jordan","year":"2016","journal-title":"Pediatr Transplant"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"issue":"6","key":"R11-20230918","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/TP.0b013e3181d62f1b","article-title":"The KDIGO clinical practice guidelines for the care of kidney transplant recipients","volume":"89","author":"Chapman","year":"2010","journal-title":"Transplantation"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/petr.12030","article-title":"Valganciclovir dosing using area under the curve calculations in pediatric solid organ transplant recipients","volume":"17","author":"Villeneuve","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R14-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12833","article-title":"Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and\/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease","volume":"21","author":"Varela-Fascinetto","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/TP.0000000000002115","article-title":"Incidence of cytomegalovirus dnaemia in pediatric kidney transplant recipients after cessation of antiviral prophylaxis","volume":"102","author":"Chaiyapak","year":"2018","journal-title":"Transplantation"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/TP.0000000000000888","article-title":"Cytomegalovirus infection in pediatric renal transplantation and the impact of chemoprophylaxis with (Val-) ganciclovir","volume":"100","author":"Hocker","year":"2016","journal-title":"Transplantation"},{"key":"R17-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12771","article-title":"Herpesviruses excretion in saliva of pediatric transplant recipients","volume":"19","author":"Correa Sierra","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/ajt.13649","article-title":"Impact of everolimus and low-dose cyclosporin on cytomegalovirus replication and disease in pediatric renal transplantation","volume":"16","author":"Hocker","year":"2016","journal-title":"Am J Transplant"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ajt.14603","article-title":"Comprehensive review of post-organ transplant hematologic cancers","volume":"18","author":"Dharnidharka","year":"2018","journal-title":"Am J Transplant"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1399-3046.2006.00641.x","article-title":"Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation","volume":"11","author":"Li","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1681\/ASN.2009111188","article-title":"Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation","volume":"21","author":"Smith","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/jcm.35.6.1612-1615.1997","article-title":"Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders","volume":"35","author":"Rowe","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00007890-199307000-00016","article-title":"Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center","volume":"56","author":"Cockfield","year":"1993","journal-title":"Transplantation"},{"key":"R26-20230918","first-page":"214","article-title":"Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations","volume":"14","author":"Walker","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1034\/j.1600-6143.2002.21019.x","article-title":"Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk","volume":"2","author":"Dharnidharka","year":"2002","journal-title":"Am J Transplant"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.juro.2010.06.028","article-title":"Risk factors for urinary tract infection after renal transplantation and its impact on graft function in children and young adults","volume":"184","author":"Silva","year":"2010","journal-title":"J Urol"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection","volume":"152","author":"Ho","year":"1985","journal-title":"J Infect Dis"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00007890-199608150-00012","article-title":"Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression","volume":"62","author":"Newell","year":"1996","journal-title":"Transplantation"},{"issue":"(Suppl 1)","key":"R31-20230918","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.12019","article-title":"OPTN\/SRTR 2011 Annual Data Report: kidney","volume":"13","author":"Matas","year":"2013","journal-title":"Am J Transplant"},{"key":"R32-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13116","article-title":"Transplantation of solid organ recipients shedding Epstein-Barr virus DNA pre-transplant: a prospective study","volume":"31","author":"Verghese","year":"2017","journal-title":"Clin Transplant"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00467-017-3627-2","article-title":"Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients","volume":"32","author":"Colombini","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"R34-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12816","article-title":"The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children","volume":"21","author":"Cameron","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"e13147","DOI":"10.1111\/petr.13147","article-title":"Epidemiology and outcome of chronic high Epstein-Barr viral load carriage in pediatric kidney transplant recipients","volume":"22","author":"Yamada","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"(Suppl 2;M3)","key":"R36-20230918","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1874303X014070100123","article-title":"Significance of asymptomatic persistent epstein-barr viral load in pediatric renal transplant recipients: North American Pediatric Renal Trials and Collaborative Studies Report","volume":"7","author":"Moudgil","year":"2014","journal-title":"Open J Urol Nephrol"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/apa.14375","article-title":"Long-term study showed that vaccination protected paediatric renal transplant recipients from life-threatening varicella zoster virus","volume":"107","author":"Lindahl","year":"2018","journal-title":"Acta Paediatr"},{"key":"R38-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12905","article-title":"Human herpes virus 6 infection in pediatric organ transplant patients","volume":"21","author":"Ylinen","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00467-010-1716-6","article-title":"The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment","volume":"26","author":"Dharnidharka","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R40-20230918","article-title":"Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN Registry Study","author":"Hocker","year":"2018","journal-title":"Transplantation"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"R42-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12942","article-title":"The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: a prospective study","volume":"21","author":"Verghese","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00467-018-4029-9","article-title":"JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study","volume":"33","author":"Hocker","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00467-018-3905-7","article-title":"Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients","volume":"33","author":"Cordts","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"e13195","DOI":"10.1111\/petr.13195","article-title":"Ribavirin therapy of hepatitis E infection may cause hyporegenerative anemia in pediatric renal transplant patients","volume":"22","author":"Klambt","year":"2018","journal-title":"Pediatr Transplant"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/jpids\/piv070","article-title":"Outcomes among children who received a kidney transplant in the united states from a hepatitis B core antibody-positive donor, 1995\u20132010","volume":"5","author":"Ruebner","year":"2016","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R47-20230918","article-title":"Outcome of the double-J stent placement in pediatric kidney transplant: a single center experience","author":"Sozen","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"R48-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13065","article-title":"How to stent the ureter after kidney transplantation in children?-A comparison of two methods of urinary drainage","volume":"22","author":"Ter Haar","year":"2018","journal-title":"Pediatr Transplant"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/tri.12888","article-title":"Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation","volume":"30","author":"Maliakkal","year":"2017","journal-title":"Transplant Int"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"459747","DOI":"10.1155\/2014\/459747","article-title":"Ureteral stent placement increases the risk for developing BK viremia after kidney transplantation","volume":"2014","author":"Hashim","year":"2014","journal-title":"J Transplant"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00467-017-3776-3","article-title":"Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation","volume":"33","author":"Hocker","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00467-017-3868-0","article-title":"Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy","volume":"33","author":"Hocker","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2215\/CJN.09690915","article-title":"Immunogenicity of human papillomavirus recombinant vaccine in children with CKD","volume":"11","author":"Nelson","year":"2016","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201904000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:03:22Z","timestamp":1695002602000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201904000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000728","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}